ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,042 | -8,671 | -4,051 | -17,425 | -16,260 |
| Depreciation Amortization | 96 | 63 | 29 | 43 | 34 |
| Accounts receivable | 192 | 112 | -127 | -215 | -68 |
| Other Working Capital | 125 | -630 | -786 | 639 | 1,510 |
| Other Operating Activity | 2,336 | 560 | 475 | 1,422 | 1,706 |
| Operating Cash Flow | $-12,294 | $-8,566 | $-4,460 | $-15,536 | $-13,078 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,026 | 3,026 | 3,026 | 11,980 | 3,003 |
| PPE Investments | -153 | -153 | -153 | -651 | -253 |
| Investing Cash Flow | $2,873 | $2,874 | $2,874 | $11,329 | $2,750 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,341 | -15 | -13 | 380 | 380 |
| Other Financing Activity | -511 | -68 | 0 | -60 | 0 |
| Financing Cash Flow | $10,830 | $-83 | $-13 | $319 | $380 |
| Beginning Cash Position | 11,761 | 11,761 | 11,761 | 15,649 | 15,649 |
| End Cash Position | 13,169 | 5,986 | 10,162 | 11,761 | 5,701 |
| Net Cash Flow | $1,408 | $-5,775 | $-1,599 | $-3,888 | $-9,948 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,294 | -8,566 | -4,460 | -15,536 | -13,078 |
| Capital Expenditure | -153 | -153 | -153 | -651 | -253 |
| Free Cash Flow | -12,448 | -8,719 | -4,612 | -16,187 | -13,331 |